Results for “”

Entry Author Date Location
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
Amazon Sets Electric Vehicle, Carbon Footprint Goals Amid Criticism 09/19/19 Seattle
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation? 09/19/19 National
New Deals May Double $240M Funding For MIT-IBM AI Lab, Director Says 09/19/19 Boston
Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M 09/19/19 San Diego
Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market 09/16/19 National
Why Menlo Ventures Backed Construction Tech Firm Fieldwire 09/16/19 San Francisco
Cloudflare’s $525M IPO Emboldens Already-Confident Internet Booster 09/13/19 San Francisco
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
Booming CS Demand Brings Ex-Acquia CEO Back to His UW Roots 09/13/19 Wisconsin
The Winners of the 2019 Xconomy Awards Boston Are… 09/12/19 Boston
John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22 09/12/19 Boston
FDA Doesn’t Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb 09/11/19 San Francisco
Phil Sharp, CRISPR’ing the Heart & the Duchenne Data Gap on Oct. 17 09/11/19 Boston
After First Look at House Drug Plan, Stocks Rise Slightly 09/10/19 National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards 09/10/19 National
Shopify Buys 6 River Systems for $450M to Boost Fulfillment Centers 09/10/19 Boston
Amazon, With More WA Workers than Microsoft, Eyes Adding 10K More 09/09/19 Seattle
Epstein Fallout: Joi Ito Resigns From MIT Media Lab, Multiple Boards 09/09/19 Boston
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Bankrupt uBiome Says Founders May Have Misled Investors 09/04/19 San Francisco
Vertex Bets $950M on Semma and a Stem Cell Therapy for Diabetes 09/03/19 Boston
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing 09/02/19 New York
Robocalls Crowd Out Real Business Calls. This Startup Has an Answer. 08/30/19 Seattle
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
$5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop 08/29/19 Detroit Ann Arbor
ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation 08/28/19 San Francisco
NuTonomy Switches to Chrysler For More Elbow Room in Self-Driving Cars 08/27/19 Boston
Page 1 of 233 next page »